Research Article
[Retracted] Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
Figure 3
OS analysis of CDCA3 in pan-cancer. (a) The forest plot shows the univariate Cox analysis of CDCA3 gene in OS of various tumor patients, including value, risk coefficient HR, and confidence interval. (b) Heatmap showing OS of CDCA3 gene in pan-cancer. (c–l) Kaplan-Meier curves show OS of CDCA3 gene in ACC, KIRC, KIRP, LGG, LIHC, LUAD, MESO, PAAD, SARC, and SKCM.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |
(i) |
(j) |
(k) |
(l) |